Correlation Between Alx Oncology and Rani Therapeutics

Can any of the company-specific risk be diversified away by investing in both Alx Oncology and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alx Oncology Holdings and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Alx Oncology and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and Rani Therapeutics.

Diversification Opportunities for Alx Oncology and Rani Therapeutics

-0.45

Correlation Coefficient

Alx Oncology  Rani Therapeutics

Very good diversification

The 3 months correlation between Alx and Rani is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Alx Oncology i.e., Alx Oncology and Rani Therapeutics go up and down completely randomly.

Pair Corralation between Alx Oncology and Rani Therapeutics

Given the investment horizon of 90 days Alx Oncology Holdings is expected to under-perform the Rani Therapeutics. In addition to that, Alx Oncology is 1.37 times more volatile than Rani Therapeutics Holdings. It trades about -0.16 of its total potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about 0.03 per unit of volatility. If you would invest  142.00  in Rani Therapeutics Holdings on December 26, 2024 and sell it today you would earn a total of  2.00  from holding Rani Therapeutics Holdings or generate 1.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Alx Oncology Holdings  vs.  Rani Therapeutics Holdings

Alx Oncology Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Rani Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Rani Therapeutics Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Rani Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Alx Oncology and Rani Therapeutics

The main advantage of trading using opposite Alx Oncology and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.

The idea behind Alx Oncology Holdings and Rani Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.